Greenwich Lifesciences Stock Probability of Future Stock Price Finishing Over 13.33
| GLSI Stock | USD 13.33 0.06 0.45% |
Greenwich |
Greenwich Lifesciences Target Price Odds to finish over 13.33
The tendency of Greenwich Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 13.33 | 90 days | 13.33 | about 80.81 |
Based on a normal probability distribution, the odds of Greenwich Lifesciences to move above the current price in 90 days from now is about 80.81 (This Greenwich Lifesciences probability density function shows the probability of Greenwich Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.77 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Greenwich Lifesciences will likely underperform. Additionally Greenwich Lifesciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Greenwich Lifesciences Price Density |
| Price |
Predictive Modules for Greenwich Lifesciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Greenwich Lifesciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Greenwich Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Greenwich Lifesciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Greenwich Lifesciences is not an exception. The market had few large corrections towards the Greenwich Lifesciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Greenwich Lifesciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Greenwich Lifesciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.31 | |
β | Beta against Dow Jones | 1.77 | |
σ | Overall volatility | 0.62 | |
Ir | Information ratio | -0.07 |
Greenwich Lifesciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Greenwich Lifesciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Greenwich Lifesciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Greenwich Lifesciences generated a negative expected return over the last 90 days | |
| Greenwich Lifesciences has high historical volatility and very poor performance | |
| Greenwich Lifesciences has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (8.89 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Greenwich Lifesciences currently holds about 15.64 M in cash with (6.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.22. | |
| Greenwich Lifesciences has a frail financial position based on the latest SEC disclosures | |
| Roughly 53.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: Greenwich LifeSciences, Inc. VP Purchases 12,910.00 in Stock |
Greenwich Lifesciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Greenwich Stock often depends not only on the future outlook of the current and potential Greenwich Lifesciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Greenwich Lifesciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 12.8 M | |
| Cash And Short Term Investments | 7 M | |
| Shares Float | 5.9 M |
Greenwich Lifesciences Technical Analysis
Greenwich Lifesciences' future price can be derived by breaking down and analyzing its technical indicators over time. Greenwich Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Greenwich Lifesciences. In general, you should focus on analyzing Greenwich Stock price patterns and their correlations with different microeconomic environments and drivers.
Greenwich Lifesciences Predictive Forecast Models
Greenwich Lifesciences' time-series forecasting models is one of many Greenwich Lifesciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Greenwich Lifesciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Greenwich Lifesciences
Checking the ongoing alerts about Greenwich Lifesciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Greenwich Lifesciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Greenwich Lifesciences generated a negative expected return over the last 90 days | |
| Greenwich Lifesciences has high historical volatility and very poor performance | |
| Greenwich Lifesciences has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (8.89 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Greenwich Lifesciences currently holds about 15.64 M in cash with (6.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.22. | |
| Greenwich Lifesciences has a frail financial position based on the latest SEC disclosures | |
| Roughly 53.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: Greenwich LifeSciences, Inc. VP Purchases 12,910.00 in Stock |
Check out Greenwich Lifesciences Backtesting, Greenwich Lifesciences Valuation, Greenwich Lifesciences Correlation, Greenwich Lifesciences Hype Analysis, Greenwich Lifesciences Volatility, Greenwich Lifesciences History as well as Greenwich Lifesciences Performance. For more detail on how to invest in Greenwich Stock please use our How to Invest in Greenwich Lifesciences guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich Lifesciences. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.81) | Return On Assets (0.72) | Return On Equity (1.24) |
The market value of Greenwich Lifesciences is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Greenwich Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich Lifesciences' market value can be influenced by many factors that don't directly affect Greenwich Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Greenwich Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Greenwich Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.